Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/4926
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUma Maheswari-
dc.date.accessioned2026-05-29T10:31:55Z-
dc.date.available2026-05-29T10:31:55Z-
dc.date.issued2026-05-29-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/4926-
dc.descriptionVol. 58, No. 2, p 109en_US
dc.language.isoenen_US
dc.subjectDiabeticsen_US
dc.subjectdyslipidemiaen_US
dc.subjectgemfibrozilen_US
dc.subjectperoxisome proliferator-activated recepotor-alpha α/ʏ agonisten_US
dc.subjectsaroglitazar and high-density lipoproteinen_US
dc.titleTherapy in diabetic dyslipidemiaen_US
dc.typeOtheren_US
Appears in Collections:Vol 58, No. 2, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol. 58, No. 2, p 10987.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.